Presentation TCT 2017 DEBATE: Mechanical Hemodynamic Support in Cardiogenic Shock Should be Used in All Patients! Presenter: Michael Mooney, Holger Thiele, Tanveer Rab October 31, 2017
Presentation TCT 2017 Trial Design Considerations for Percutaneous Mechanical Support Devices: Necessity, Challenges, and Lessons Learned Presenter: David E. Kandzari, Jaime Raben October 31, 2017
Presentation TCT 2017 Mechanical Hemodynamic Support Should be Established Before Revascularization: Results From the US Impella Registry Presenter: Michael Mooney, Holger Thiele, Brian P O'Neill October 31, 2017
Presentation TCT 2017 Mechanical Hemodynamic Support: Counterpulsation, Rotary Flow, or ECMO for Cardiogenic Shock, and Why? Presenter: Michael Mooney, Holger Thiele, Navin K. Kapur October 31, 2017
Presentation TCT 2017 Is There a Role for Dedicated Stents for the Left Main Bifurcation? Rationale and Device Landscape (With Case Examples) Presenter: David Hildick-Smith, Jeffrey W. Moses, Carlo Briguori October 31, 2017
Presentation TCT 2017 Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device Presenter: Stephen G. Ellis, Takeshi Kimura, Hiram G. Bezerra October 31, 2017
Presentation TCT 2017 Debate: ABSORB Is Likely Finished - The Limitation of the Technology Can Not Be Overcome Presenter: Stephen G. Ellis, Takeshi Kimura, Robert A. Byrne October 31, 2017
Presentation TCT 2017 Cardiac Catheterization, Mechanical Support, and Hypothermia in Patients With Cardiac Arrest: State-of-the-Art Presenter: Michael Mooney, Holger Thiele, Sandeep Nathan October 31, 2017
Presentation TCT 2017 Firehawk Sirolimus-Eluting Stent: Device Specifications and Clinical Program Update Presenter: Manel Sabate, Joanna J. Wykrzykowska, Qi Zhang October 31, 2017
Presentation TCT 2017 The Potential For BRS: What Weve Learned From Pushing The Envelope Presenter: Stephen G. Ellis, Takeshi Kimura, Corrado Tamburino October 31, 2017
Presentation TCT 2017 Should the Approach to Multivessel Disease Differ in Patients With and Without Cardiogenic Shock? Presenter: Michael Mooney, Holger Thiele October 31, 2017
Presentation TCT 2017 Buma Stent: Device Specifications, Clinical Trial Results, and Global Development Presenter: Manel Sabate, Joanna J. Wykrzykowska, Kefei Dou October 31, 2017
Presentation TCT 2017 Registry Update: ABSORB SCAAR Presenter: Stephen G. Ellis, Takeshi Kimura, Stefan K. James October 31, 2017
Presentation TCT 2017 Hub and Spoke Transfer Strategies in Cardiogenic Shock and Cardiac Arrest: Any Benefit on Outcome? Presenter: Michael Mooney, Holger Thiele, Christopher B. Granger October 31, 2017
Presentation TCT 2017 Registry Update: BVS STEMI STRATEGY Presenter: Stephen G. Ellis, Takeshi Kimura, Alfonso Ielasi October 31, 2017
Presentation TCT 2017 Abluminus Sirolimus-Eluting Stent: Specifications and Clinical Development Presenter: Manel Sabate, Joanna J. Wykrzykowska, Luca Testa October 31, 2017
Presentation TCT 2017 Improving Outcomes in Cardiogenic Shock: Issues the Guidelines Dont Discuss Presenter: Michael Mooney, Holger Thiele, Venu Menon October 31, 2017
Presentation TCT 2017 The DESyne Novolimus-Eluting Coronary Stent: Results From the Excella Trials Presenter: Manel Sabate, Joanna J. Wykrzykowska, Javaid Iqbal October 31, 2017
Presentation TCT 2017 Registry Update: IT-DISAPPEARS Presenter: Stephen G. Ellis, Takeshi Kimura, Francesco Bedogni October 31, 2017
Presentation TCT 2017 Registry Update: FRANCE ABSORB Presenter: Stephen G. Ellis, Takeshi Kimura, Didier Carrié October 31, 2017